Nurexone Biologic أخبار Eulerpool

Nurexone Biologic إيولربول AFX

أخبار سهم Nurexone Biologic

يتابع Nurexone Biologic العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Nurexone Biologic.

• ٢٩ يوليو ·

  Yahoo
  NurExone Announces Further Expansion of ExoPTEN Patent Coverage
• ١٧ يوليو ·

  Yahoo
  Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
• ١٧ يوليو ·

  Yahoo
  Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
• ٥ يوليو ·

  Yahoo
  Updates from NurExone: Growth Conference Presentation and Website Relaunch
• ٢٨ يونيو ·

  Yahoo
  NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
• ٢١ يونيو ·

  Yahoo
  On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
• ١١ يونيو ·

  Yahoo
  NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
• ٤ يونيو ·

  Yahoo
  NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
• ٣١ مايو ·

  Yahoo
  Is NurExone Biologic (CVE:NRX) In A Good Position To Deliver On Growth Plans?
• ٢٩ مايو ·

  Yahoo
  NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials